Holian. Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells.
LYSOPHOSPHATIDYLCHOLINE (LPC) is a proinflammatory and atherogenic serum lysophospholipid that activates a variety of cell types, including the vascular endothelium (6, 8, 9, 13, 15, 24) . Endothelial cells stimulated with LPC are shown to upregulate endothelial cell adhesion molecules such as ICAM-1, VCAM-1, and P-selectin (8, 14, 26) and growth factors (17) . Moreover, LPC-activated endothelium secretes cytokines, matrix metalloproteinases, O 2 Ϫ , as well as arachidonic acid (4, 7, 20, 21, 23) . Thus LPC stimulates multiple inflammatory activities in the vascular endothelium.
LPC can activate several second messenger pathways, including protein kinase C, extracellular signalregulated kinases, tyrosine kinases, and Ca 2ϩ (2, 16, 19, 26) , implicating engagement of transduction mechanisms. Recent evidence suggests that two cloned orphan G protein-coupled receptors, GPR4 and G2A, may be specific LPC receptors in immune and tumor cells (5, 25) . In these reports, the ectopically expressed receptors demonstrated high binding affinity and specificity with LPC. The physiological function and endogenous expression of LPC receptors by the vascular endothelium, as well as the consequent pathological implications, have yet to be fully elucidated. The goal of the present study was to investigate the intriguing possibility that endothelium may express endogenous GPR4 and G2A by which LPC mediates inflammatory responses.
MATERIALS AND METHODS
For these studies, we cultured human microvascular endothelial cells from two different vascular beds, brain (HB-MEC) and dermis (HMEC). HBMEC were grown in RPMI 1640 supplemented with 10% FBS, 10% NuSerum (Becton Dickinson; Bedford, MA), endothelial cell growth supplement (30 g/ml), heparin (5 U/ml), 1 mmol/l sodium pyruvate, 1 mmol/l minimal essential media (MEM), nonessential amino acids, 1 mmol/l MEM vitamins, 1% L-glutamine, and 1% penicillin-streptomycin. HMEC were cultured in MCDB 131 medium (GIBCO-BRL; Gaithersburg, MD) supplemented with 5% FBS (Hyclone; Logan, UT), 10 g/l human epidermal growth factor, 1 mg/l hydrocortisone, 1% penicillin-streptomycin, and 1% L-glutamine. Both HBMEC (18) and HMEC (1, 11) express the endothelial phenotype and demonstrate endothelial functional characteristics.
The expression of GPR4 and G2A mRNAs in HBMEC and HMEC was determined by RT-PCR as described previously (10) . Total RNA was extracted from confluent monolayers of HBMEC or HMEC treated for 2 h or overnight with either TNF-␣ (100 U/ml) or H 2O2 (50 mol/l), as well as from human lymphocytes as a positive control. Total RNA was reverse transcribed with oligo-dT primers, and PCR was performed with specific primer sets corresponding to GenBank sequences of human GPR4 (5Ј ϭ CAT CGC CTT CCT GTG CTG CA; 3Ј ϭ AAG AGC ACG TGA TAG GGC GC) and G2A (5Ј ϭ ATG TGC CCA ATG CTA CTG; 3Ј ϭ GTT CAC CGT GGA CAG GCA CA). RT-PCR products were analyzed by 1.5% agarose gel electrophoresis.
Specific binding of LPC (1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine; Avanti Polar Lipids, Alabaster, AL) to endothelial cell surface was determined by competition binding assays. Confluent cell monolayers grown in 24-well culture dishes were treated overnight with either TNF-␣ (100 U/ml) or H 2O2 (50 mol/l). After three washes with cold HEPES buffer, cells were lysed with 0.1 mol/l NaOH, radioactivity was counted, and specific binding from duplicate samples was calculated (as fmol LPC bound/10 6 cells). Separate dishes of cells were treated in parallel for cell count determination.
RESULTS AND DISCUSSION
A major finding is that human endothelial cells from two different vascular beds, brain and skin, expressed the LPC receptor GPR4 mRNA (Fig. 1) but not G2A mRNA (Fig. 2) . This selectivity for GPR4 expression by endothelial cells is consistent with the report that GPR4 appears to have wide tissue distribution, including the ovary, lung, kidney, liver, brain, and lymph nodes (25) . Our current finding suggests that this wide distribution in tissue expression extends to the vascular endothelium as well. In contrast, G2A was not expressed by either endothelial cell types but was detected in human lymphocytes serving as a positive control (Fig. 2) . This observation is consistent with reports indicating that G2A is found predominantly in tissues rich in lymphocytes such as spleen and thymus and to a lessor extent in other tissues such as the heart and lung (22) .
The pattern of constitutive GPR4 mRNA expression by the two endothelial cell types was considerably different. HBMEC expressed barely detectable levels of constitutive GPR4 (the predicted 419-bp product was detected only at increased PCR cycles; data not shown), whereas the basal expression of GPR4 mRNA in HMEC was higher than that in HBMEC. The findings suggest that HMEC may have greater surface expression of endogenous GPR4 protein than HBMEC. Our laboratory is at present developing an antibody to GPR4 to investigate this hypothesis.
We next determined whether inflammatory stress induces GPR4 expression in HBMEC and HMEC. Evidence to date indicates that LPC receptors appear to be inducible by a wide range of signals, including DNA-damaging reagents, stress, and apoptosis (22) . HBMEC and HMEC were stimulated by the cytokine TNF-␣ or the oxidant H 2 O 2 for 2 h or overnight. The results indicated that in HBMEC, but not HMEC, stimulation with TNF-␣ or H 2 O 2 increased GPR4 mRNA over control within 2 h (Fig. 1) , which was sustained overnight (data not shown). Subsequent sequencing of the purified bands in both forward and reverse directions (Research Resources Center, University of Illinois at Chicago) and BLAST 2.0 analysis (Basic Local Alignment Search Tool, NCBI) indicated that the GPR4 DNA sequences had 96-97% identity with gene database sequences, corresponding to E values Ͻ10
Ϫ160
. Thus results indicated that GPR4 was increased by TNF-␣ and H 2 O 2 stimuli. Although reasons for the selective upregulation of GPR4 in HBMEC but not in HMEC are not apparent from this study, the findings do suggest that cerebral vascular endothelium appear to be highly sensitive to inflammatory stresses in the context of LPC receptor expression, which may lead to enhanced responsiveness to LPC. In contrast, neither HBMEC (Fig. 2) nor HMEC express G2A, the other LPC receptor; furthermore, TNF-␣ or H 2 O 2 was ineffective in induction of its expression.
We also evaluated the relation of GPR4 expression and specific binding of LPC to endothelial cells following inflammatory stress. (25) , suggesting that endothelial cells may also be activated by SPC through GPR4.
In conclusion, our results indicated that of the known receptors for LPC to date, vascular endothelial cells selectively expressed GPR4 but not G2A. Furthermore, GPR4 expressed in brain endothelial cells was inducible by inflammatory stresses such as cytokines and oxidants, and this ability appears to be tissue specific. We conclude that the endogenous GPR4 expressed in the endothelium may provide a G proteincoupled receptor mechanism by which the highly proinflammatory LPC signals cellular responses.
